Nextage Therapeutics Financials
| MCTC Stock | ILA 73.30 1.60 2.14% |
Nextage |
Please note, the presentation of Nextage Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Nextage Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Nextage Therapeutics' management manipulating its earnings.
Nextage Therapeutics Stock Summary
Nextage Therapeutics competes with Kamada, Bezeq Israeli, B Communications, Photomyne, and M Yochananof. Micromedic Technologies Ltd develops and commercializes in-vitro cancer diagnostic products and solutions worldwide. Further, the company provides diagnostic solutions for multiple cancer diagnostic applications. MICROMEDIC TECHNOL operates under Drug ManufacturersSpecialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange.| Foreign Associate | USA |
| Instrument | Israel Stock View All |
| Exchange | Tel Aviv Stock Exchange |
| ISIN | IL0004330119 |
| Business Address | Building 7, Entrance |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.m-medic.com |
| Phone | 972 73 2753450 |
| Currency | ILA |
You should never invest in Nextage Therapeutics without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Nextage Stock, because this is throwing your money away. Analyzing the key information contained in Nextage Therapeutics' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Nextage Therapeutics Key Financial Ratios
Nextage Therapeutics' financial ratios allow both analysts and investors to convert raw data from Nextage Therapeutics' financial statements into concise, actionable information that can be used to evaluate the performance of Nextage Therapeutics over time and compare it to other companies across industries.| Return On Asset | -0.37 | |||
| Beta | 1.05 | |||
| Z Score | -23.8 |
Nextage Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nextage Therapeutics's current stock value. Our valuation model uses many indicators to compare Nextage Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nextage Therapeutics competition to find correlations between indicators driving Nextage Therapeutics's intrinsic value. More Info.Nextage Therapeutics is regarded fourth in return on asset category among its peers. It also is regarded fourth in profit margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nextage Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nextage Therapeutics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Nextage Therapeutics Systematic Risk
Nextage Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Nextage Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Nextage Therapeutics correlated with the market. If Beta is less than 0 Nextage Therapeutics generally moves in the opposite direction as compared to the market. If Nextage Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Nextage Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Nextage Therapeutics is generally in the same direction as the market. If Beta > 1 Nextage Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Nextage Therapeutics December 13, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Nextage Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Nextage Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Nextage Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Nextage Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Nextage Therapeutics's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.9 | |||
| Information Ratio | 0.0722 | |||
| Maximum Drawdown | 40.45 | |||
| Value At Risk | (8.03) | |||
| Potential Upside | 12.0 |
Complementary Tools for Nextage Stock analysis
When running Nextage Therapeutics' price analysis, check to measure Nextage Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nextage Therapeutics is operating at the current time. Most of Nextage Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nextage Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nextage Therapeutics' price. Additionally, you may evaluate how the addition of Nextage Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |